Results 1 to 10 of about 162,682 (253)

When Infection Meets Inflammation: <i>Listeria monocytogenes</i> and Host Signaling Pathways. [PDF]

Biology (Basel)
Jia Y, Yang K, Guo R, Ding K, Wang S, Chen S.   +5 more
europepmc   +1 more source

Curcumin Induces Pyroptosis-Associated Molecular Changes in Osteosarcoma Cells Correlating with the ROS/NLRP3/CASPASE-1/GSDMD Axis with Concomitant PI3K/AKT Suppression and Apoptosis Activation. [PDF]

Nutrients
Yuan K, Zhao X, Guo J, Lu Y, Cui Y, Zhang W, Zhu W.   +6 more
europepmc   +1 more source

Carbon-ion beam irradiation combined with miR-17-5p/miR-17-3p inhibitors effectively kill osteosarcoma cells. [PDF]

Am J Cancer Res
Kim EH, Lee WS, Sai S.
europepmc   +1 more source

Pyroptosis in epilepsy: from pathophysiological mechanisms to therapeutic strategies. [PDF]

Front Cell Dev Biol
Chen Q, Yang YT, Cai L, Zhang HQ, Yang J.   +4 more
europepmc   +1 more source

Retraction: Exploring novel fluorine-rich fuberidazole derivatives as hypoxic cancer inhibitors: Design, synthesis, pharmacokinetics, molecular docking, and DFT evaluations. [PDF]

PLoS One
PLOS One Editors.
europepmc   +1 more source

Unraveling the complexity of pyroptosis in esophageal cancer: from underlying mechanisms to targeted therapies. [PDF]

Cancer Cell Int
Yang W, Wen J, Tang L, Zhan M.
europepmc   +1 more source

Targeting pyroptosis in renal fibrosis: From molecular mechanisms to therapeutic horizons (Review). [PDF]

Int J Mol Med
Tian Y, Mushuo Q, Fan H, Su H, Li J, Zhang Q.   +5 more
europepmc   +1 more source

Targeting mitochondria as a potential therapeutic strategy against radioresistance in cancer. [PDF]

Front Oncol
Nazam N, Sadiya S, Khan S, Misra A, Sureka N, Panwar K, Sahani N, Zaheer S.   +7 more
europepmc   +1 more source

Deciphering the mechanistic involvement of PANoptosis in FC-MDD comorbidity through the gut-brain axis. [PDF]

Front Immunol
Ma Y, Wang S, Wei W, Cheng C.
europepmc   +1 more source

Pharmacological targeting of the NLRP3 LRR domain with isothiazolinones overcomes CRID3-resistant inflammation. [PDF]

EMBO Mol Med
Woo H, Jang Y, Kim S, Kim W, Zhang F, Mall R, Patel CN, Kurera M, Ngo C, Jiang SH, Nicotra A, Py BF, Zheng M, Man SM, Karki R.   +14 more
europepmc   +1 more source